logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
T

Tatsunori Shimoi

National Cancer Center Hospital
H指数:21
被引数:2,476

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

B7-H4‒directed antibody-drug conjugate AZD8205 (puxitatug samrotecan) in patients with advanced/metastatic solid tumors: the Phase 1/2a (BLUESTAR), first-in-human study

B7-H4靶向抗体药物偶联物AZD8205（puxitatug samrotecan）在晚期/转移性实体瘤患者中的I/IIa期（BLUESTAR）首次人体研究

Nature Communications
IF15.7
2026-10-300
OAAI
Funda Meric-Bernstam; Yoichi Naito; Stephanie Gaillard; Tatsunori Shimoi; Vincent Chung; Andrew A. Davis; Theresa A. Proia; Jixin Wang; Vincent F. S. Dubois; Marlon C. Rebelatto; Mary McFarlane; Minal Kulkarni; Shreyas Upadhyay; Jun Tian; Neil Miller; Nadia Luheshi; Andreea Varga; Do-Youn Oh; Linda Mileshkin
Central nervous system symptom burden and clinical implications for antiemetic management with olanzapine in AC chemotherapy

中枢神经系统症状负担及奥氮平在AC化疗中抗恶心管理的临床意义

Oncologist
IF4.2
2026-09-090
OAAI
Ryoko Udagawa; Mototsugu Shimokawa; Hirotoshi Iihara; Rie Ozeki; Michiko Tsuneizumi; Manabu Futamura; Tomoyuki Fujita; Hideaki Ogata; Hiroko Bando; Toshitaka Uomori; Hironobu Hashimoto; Ryosuke Hayami; Yoshihisa Tokumaru; Goro Kutomi; Kan Yonemori; Ryoichi Matsunuma; Mika Kitahora; Naotake Yanagisawa; Tatsunori Shimoi; Mitsue Saito; null
Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort

基于基因组分析的第二阶段临床试验：BELIEVE试验（NCCH1901）亚组研究

Cancer Science
IF4.3
2026-08-180
OAAI
Masashi Kanai; Kuniko Sunami; Tatsunori Shimoi; Satoshi Nishiwaki; Ichiro Kinoshita; Tetsuhiro Yoshinami; Chigusa Morizane; Yusuke Sato; Toshio Kubo; Mamoru Ito; Hiroshi Nishihara; Toru Mukohara; Hidekazu Shirota; Ryo Ko; Taro Shibata; Manabu Muto; Noboru Yamamoto
Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE

转移性三阴性乳腺癌患者中阿替利珠单抗联合白蛋白结合型紫杉醇的队列观察性研究：JBCRG-C08/ATTRIBUTE

npj Breast Cancer
IF7.6
2026-06-260
OA
Tatsunori Shimoi; Nobuhiro Shibata; Masahiro Kitada; Michiko Tsuneizumi; Mitsugu Yamamoto; Yukinori Ozaki; Yumi Fujimoto; Sayuri Akiyoshi; Naoki Hashimoto; Miki Yamaguchi; Yutaka Yamamoto; Norikazu Masuda; Hiroshi Tada; Takashi Yamanaka; Yuichiro Kikawa; Tetsuhiko Taira; Shizuka Nakagawa; Taizo Takahashi; Mari S. Oba; Naoki Niikura
Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer

从HercepTest到4B5的HER2重新评估在转移性乳腺癌中的临床意义

Breast Cancer Research and Treatment
IF3
2026-06-220
OA
Yuhei Yamaguchi; Mai Hoshino; Tatsunori Shimoi; Hiroki Tamura; Yutaka Natori; Takuro Saiki; Taro Yamanaka; Rui Kitadai; Ayumi Saito; Shosuke Kita; Aiko Maejima; Yuki Kojima; Kazuki Sudo; Akiko Miyagi Maeshima; Takeshi Murata; Shin Takayama; Yasuto Naoi; Kan Yonemori; Masayuki Yoshida
Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10)

随机化、多中心II期研究：贝伐珠单抗和紫杉醇诱导后使用阿替利珠单抗和nab-紫杉醇治疗PD-L1阳性转移性三阴性乳腺癌患者的方案（INDUCE试验[JBCRG-M10]）

BMJ Open
IF2.3
2026-05-130
PRE
Ozaki, Yukinori; Koyama, Shohei; Morita, Satoshi; Miyashita, Minoru; Tokuda, Emi; Shimoi, Tatsunori; Fukuoka, Megumi; Masuda, Hiroko; Takano, Yuko; Shibata, Nobuhiro; Yoshinami, Tetsuhiro; Murakami, Akari; Tamaki, Kentaro; Ishiguro, Hiroshi; Saji, Shigehira; Miwa, Asako; Matsunaga, Junko; Zheng, Yue; Nishikawa, Hiroyoshi; Masuda, Norikazu
MTAP loss in advanced mucinous ovarian carcinoma: Prevalence, co-alteration patterns, and prognostic association in a nationwide Japanese genomic registry

MTAP缺失在晚期黏液性卵巢癌中的流行率、共突变模式和预后关联：一项基于日本全国基因组登记研究

Gynecologic Oncology
IF4.1
2026-04-230
PRE
Taro Yamanaka; Yuki Kojima; Jun Sato; Hiroki Tamura; Yutaka Natori; Takuro Saiki; Mai Hoshino; Ayumi Saito; Shosuke Kita; Aiko Maejima; Tatsunori Shimoi; Kazuki Sudo; Takafumi Koyama; Kan Yonemori
Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer

POLH和RAD51基因的种系变异是激素受体阴性年轻发病乳腺癌风险的候选变异。

npj Breast Cancer
IF7.6
2025-11-280
OAAI
Shu Yazaki; Rui Kitadai; Yukihide Momozawa; Teruhiko Yoshida; Takashi Yamanaka; Sho Shiino; Chisako Yamauchi; Kenichi Harano; Motonobu Saito; Yosuke Hirotsu; Hisaki Aiba; Ryuji Hamamoto; Chikako Shimizu; Akihiko Shimomura; Tatsunori Shimoi; Kazuki Sudo; Masayuki Yoshida; Kuniko Sunami; Yuichi Shiraishi; Aya Kuchiba; Megumi Hori; Kota Katanoda; Sadaaki Takata; Ayumi Ogawa; Masahiro Torasawa; Akifumi Mochizuki; Yoko Shimada; Kengo Hiranuma; Erisa Fujii; Makoto Hirata; Yuji Yamashita; Takahiro Kogawa; Takeshi Murata; Saori Fujiwara; Yohei Miyagi; Hiroshi Nakagomi; Kazunoshin Tachibana; Koichi Matsuda; Yoshinori Murakami; Katsushi Tokunaga; Yosuke Kawai; Biobank Japan Project; Masao Omata; Tohru Ohtake; Akihiko Suto; Tatsuya Onishi; Yoichi Naito; Toshinari Yamashita; Kan Yonemori; Takashi Kohno; Kouya Shiraishi
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancer

monarchE试验中高风险HR阳性、HER2阴性乳腺癌队列1的基线风险变异性与纳入标准的关系

Breast Cancer
IF2.9
2025-07-280
OA
Mai Hoshino; Tatsunori Shimoi; Taro Yamanaka; Rui Kitadai; Munehiro Ito; Ayumi Saito; Shosuke Kita; Asuka Kawachi; Hitomi Sumiyoshi Okuma; Aiko Maejima; Yuki Kojima; Kazuki Sudo; Emi Noguchi; Yasuhiro Fujiwara; Jun Kato; Kan Yonemori
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine

eribulin或卡培他滨治疗HER2-null和HER2-low晚期乳腺癌的临床病理和预后特征

BREAST CANCER
IF2.9
2024-08-142
OAAI
Kitadai, Rui; Shimoi, Tatsunori; Yazaki, Shu; Okuma, Hitomi Sumiyoshi; Hoshino, Mai; Ito, Munehiro; Saito, Ayumi; Kita, Shosuke; Kojima, Yuki; Nishikawa, Tadaaki; Sudo, Kazuki; Noguchi, Emi; Fujiwara, Yasuhiro; Yoshida, Masayuki; Yonemori, Kan
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
2024-04-0228
PRE
Leon-Ferre, Roberto A.; Jonas, Sarah Flora; Salgado, Roberto; Loi, Sherene; de Jong, Vincent; Carter, Jodi M.; Nielsen, Torsten O.; Leung, Samuel; Riaz, Nazia; Chia, Stephen; Jules-Clement, Gerome; Curigliano, Giuseppe; Criscitiello, Carmen; Cockenpot, Vincent; Lambertini, Matteo; Suman, Vera J.; Linderholm, Barbro; Martens, John W. M.; van Deurzen, Carolien H. M.; Timmermans, A. Mieke; Shimoi, Tatsunori; Yazaki, Shu; Yoshida, Masayuki; Kim, Sung-Bae; Lee, Hee Jin; Dieci, Maria Vittoria; Bataillon, Guillaume; Vincent-Salomon, Anne; Andre, Fabrice; Kok, Marleen; Linn, Sabine C.; Goetz, Matthew P.; Michiels, Stefan

研究方向

暂未获取到该数据
K
Kan Yonemori
H 指数:48论文数:1,048被引数:1.0万
K
Kazuki Sudo
H 指数:29论文数:491被引数:3,010
E
Emi Noguchi
H 指数:17论文数:133被引数:1,075
Y
Yasuhiro Fujiwara
H 指数:65论文数:973被引数:1.7万
Y
Yuki Kojima
H 指数:20论文数:349被引数:1,492
T
Tadaaki Nishikawa
H 指数:17论文数:174被引数:1,749
H
Hitomi Sumiyoshi Okuma
H 指数:14论文数:260被引数:571
C
Chikako Shimizu
H 指数:37论文数:354被引数:6,405
M
Mayu Yunokawa
H 指数:34论文数:271被引数:6,012
K
Kenji Tamura
H 指数:62论文数:658被引数:2.1万